Antidysrhythmic actions of meobentine sulfate
dc.contributor.author | Zimmerman, John M. | en_US |
dc.contributor.author | Patterson, Eugene | en_US |
dc.contributor.author | Pitt, Bertram | en_US |
dc.contributor.author | Lucchesi, Benedict Robert | en_US |
dc.date.accessioned | 2006-04-07T18:27:28Z | |
dc.date.available | 2006-04-07T18:27:28Z | |
dc.date.issued | 1984-06 | en_US |
dc.identifier.citation | Zimmerman, John M., Patterson, Eugene, Pitt, Bertram, Lucchesi, Benedict (1984/06)."Antidysrhythmic actions of meobentine sulfate." American Heart Journal 107(6): 1117-1124. <http://hdl.handle.net/2027.42/24801> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6W9H-4BTWVVS-TJ/2/c65928f43196565af53d7a518dc8f104 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/24801 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=6720538&dopt=citation | en_US |
dc.description.abstract | The antiarrhythmic efficacy of meobentine sulfate, a bethanidine derivative lacking inhibitory effects on adrenergic neuronal function, was assessed in three canine models. Intranvenous meobentine sulfate, administered in dosages of 5.0, 10,0, and 20.0 mg/kg, produced a dose-related increase in the ventricular fibrillation threshold (VFT) under nonischemic conditions (7.6 +/- 1.8 mA vs 37.8 +/- 8.6 mA) (20 mg/kg; p p p 0.05). In the conscious dog, 4 days after an anterior myocardial infarction, programmed electrical stimulation (PES) produced nonsustained ventricular tachycardia (VT) in five dogs. After meobentine sulfate administration, eight of nine animals had sustained VT and one animal developed ventricular fibrillation (VF). At a dose of 20 mg/kg, there was prolongation of the cycle length of the VT (169 +/- 11 msec to 237 +/- 20 msec), prolongation of the QRS duration (58 +/- 2.6 msec to 71 +/- 3.7 msec), and prolongation of the delay in epicardial activation. There was an enhanced potential after meobentine administration for programmed stimulation to produce ventricular arrhythmias with the introduction of fewer premature impulses. In the third canine model, conscious dogs with a previous anterior myocardial infarction developed VF in response to electrically induced left circumflex coronary artery injury. Meobentine (20 mg/kg) failed to prevent VF in eight of eight dogs. These results suggest that while meobentine sulfate significantly increases the electrical VFT, it does not protect the conscious canine from the induction of ventricular tachyarrhythmias in response to PES, and it does not prevent VF in a conscious canine model of sudden coronary death. The data would suggest that meobentine will not be effective in preventing sudden death in patients with ischemic heart disease. | en_US |
dc.format.extent | 981496 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Antidysrhythmic actions of meobentine sulfate | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Internal Medicine (Division of Cardiology), University of Michigan Medical School, Ann Arbor, Mich., USA; Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Mich., USA. | en_US |
dc.contributor.affiliationum | Department of Internal Medicine (Division of Cardiology), University of Michigan Medical School, Ann Arbor, Mich., USA; Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Mich., USA. | en_US |
dc.contributor.affiliationum | Department of Internal Medicine (Division of Cardiology), University of Michigan Medical School, Ann Arbor, Mich., USA; Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Mich., USA. | en_US |
dc.contributor.affiliationum | Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Mich., USA; Department of Internal Medicine (Division of Cardiology),University of Michigan Medical School, Ann Arbor, Mich., USA. | en_US |
dc.identifier.pmid | 6720538 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/24801/1/0000227.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0002-8703(84)90266-7 | en_US |
dc.identifier.source | American Heart Journal | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.